Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-01

Clinical Trial Update: Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating vonoprazan as first-line treatment for Helicobacter pylori eradication, reporting on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vonoprazan (vonoprazan)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: UNKNOWN